Abstract
The Experimental Oncology Unit (UNONEX) aims innovative therapies for the treatment of malignant melanoma and has been mainly focused on bioactive peptides from various sources (Dobroff et al., 2002, 2010; Polonelli et al., 2008; Matsuo, 2011; Arruda et al, 2012). We have shown that a lysine-arginine rich peptide (WT1-pTj) based on WT1 C-terminal zinc finger domain was able to inhibit mel…